- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Soma Gold Corp.
Silver47 Exploration
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Round-Up: New Mexico Sets Monthly Sales Record, Alabama Halts Medical Rollout
Many other US states have also had major news in recent weeks, with Kentucky introducing a personal possession bill and Tennessee looking to potentially crack down on products containing THCA.
New Mexico's latest cannabis data reveals a new monthly record for adult-use sales in the state.
Meanwhile, lawmakers in Tennessee are attempting to redefine what constitutes legal industrial hemp, and Kentucky has introduced a bill to allow personal use and possession of cannabis, but not sale.
Keep reading for a round-up of this week's top news and trends in the cannabis industry.
New Mexico breaks adult-use sales record
On Tuesday (January 2), the New Mexico Regulation and Licensing Department's Cannabis Reporting Online Profile released December sales figures for medical and recreational cannabis, revealing US$50.47 million in sales for the month. This brings all-time sales in the state to an impressive US$915.86 million.
As for how the two categories performed, in December, adult-use cannabis sales in the state reached US$37.47 million, setting a new record. Medical cannabis sales came to just under US$13 million, the highest level since August.
Legalization efforts in Alabama halted once again
Alabama’s efforts to provide legal access to cannabis were stopped in their tracks on Wednesday (January 3) by Montgomery County Circuit Judge James Anderson, who issued a temporary restraining order on the Alabama Medical Cannabis Commission. The judge previously blocked dispensary-only permits from being issued in December.
The state’s most recent attempt to provide licenses for medical use was the issuance of “integrated licenses,” which would have allowed five pre-selected companies — Flowerwood Medical Cannabis, Specialty Medical Products of Alabama, Sustainable Alabama, Trulieve AL and Wagon Trail Med - Serv — to cultivate, process, transport and distribute medical cannabis. Companies that were not selected have challenged the selection process, and the ongoing legal dispute has been cited as the reason for the judge's ruling.
This marks the third attempt by the commission to provide access to medical cannabis, which was legalized in 2021. Licenses were to be issued on January 9, assuming that all fees had been paid and no issues had arisen. However, Anderson has said the state may need to scrap the current round of licensing
Kentucky introduces personal possession bill
As Kentucky lawmakers roll out a policy for medical cannabis that will fully take effect on January 1, 2025, separate legislation has been introduced to legalize home cultivation, use and possession, but prohibit recreational sales.
HB 72, a limited legalization measure, would allow adults to possess up to an ounce of cannabis, 5 grams of cannabinoids, 1,000 milligrams or less of delta-8 and delta-9 THC and up to five plants. Possession of higher quantities would be grounds for a misdemeanor charge and would carry a fine and a penalty of up to 45 days in jail.
The bill was sent to Kentucky’s House Committee on Committees on Tuesday. As of the time of this writing on Friday (January 5), no amendments to the bill had been requested.
New rules for Tennessee redefine industrial hemp
Since Tennessee's Industrial Hemp Agriculture Act of 2018 legalized the cultivation, processing and sale of industrial hemp — including products containing CBD and THCA, which are non-psychoactive cannabinoids — lawmakers have made several attempts to further regulate sales.
The latest came in December, when the Tennessee Department of Agriculture introduced new rules that, if implemented, would prohibit the sale of products containing THCA; these are currently legally sold in Tennessee as flower or edibles.
This change could have significant implications for businesses that rely on the sale of these products, as well as consumers who use them. If passed, the changes could go into effect by July of this year.
A hearing on this issue has been scheduled in Nashville for February 6.
Truelieve closes deal, appointments new CFO
Truelieve (CSE:TRUL,OTCQX:TCNNF), one of the biggest multistate cannabis operators, has secured a multimillion-dollar loan that will help the company “(prepare) for growth catalysts," according to a press release.
The loan, which totals US$25 million, was provided in tandem by two banks and will be repaid at a rate of 8.31 percent over five years. First Federal Bank was the lead agent on the loan, and its president and CEO, John Medina, said in a statement, "The cannabis industry is an important and complex sector with a significant presence in Florida. We are honored to offer deposit and lending solutions, and particularly this loan to facilitate Trulieve's growth.”
The company also announced it has appointed a new CFO, Wes Getman. Trulieve’s vice president of finance, Ryan Blust, had been acting as interim CFO after Alex D’Amico’s abrupt resignation in June 2023.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Meagen moved to Vancouver in 2019 after splitting her time between Australia and Southeast Asia for three years. She worked simultaneously as a freelancer and childcare provider before landing her role as an Investment Market Content Specialist at the Investing News Network.
Meagen has studied marketing, developmental and cognitive psychology and anthropology, and honed her craft of writing at Langara College. She is currently pursuing a degree in psychology and linguistics. Meagen loves writing about the life science, cannabis, tech and psychedelics markets. In her free time, she enjoys gardening, cooking, traveling, doing anything outdoors and reading.
Learn about our editorial policies.